MCOA Website  |  About  |  Brands  |  I.R.                                                         Get FinancialNewsMedia.com Alerts 

Privacy Policy

Marijuana Company of America, Inc. (OTC: MCOA) Breaking News - July 18, 2018

 

Hemp CBD Products Offer a Natural Alternative to Synthetic-Derived Medicines


New York, NY – July 18, 2018 – CannabisNewsWire.com News Coverage:  The opioid crisis in North America has drawn attention to the urgent need for alternative medicines, and hemp CBD products offer a viable plant-based option.

  • An active ingredient in industrial hemp, Cannabidiol (CBD) can be extracted to be used in a number of different products such as topicals, tinctures, and capsules.
  • The World Health Organization (WHO) has found CBD to be nonpsychoactive, nonaddictive, and to have a positive effect on patients’ health.
  • Scientific studies have shown CBD to be effective in pain relief and, therefore, it may be a healthier alternative to addictive opioids.

Marijuana Company of America (OTC:MCOA) is actively engaged in producing all-natural products containing CBD, including a recently released pain cream that can be applied topically to relieve discomfort. Cronos Group, Inc. (NASDAQ:CRON) has recently received a boost in funds and a license to produce cannabis products in Australia, allowing the company to grow its operations. Canopy Growth Corporation (NYSE:CGC), which produces oils containing CBD, is expanding into Lesotho and Colombia, exploring a global pain-relief market. Aurora Cannabis, Inc. (OTC:ACBFF), which already produces a wide range of medical marijuana strains, is in the process of acquiring an R&D company to strengthen its offerings. And Organigram Holdings, Inc. (OTC:OGRMF) produces medical strains that include a CBD option for patients and care providers eager to benefit from this ingredient.

The Opioid Epidemic

The United States is facing one of its greatest medical crises in decades — the opioid epidemic. During 2016 alone, 42,249 people died of opioid overdoses, 115 deaths every day. Despite the attention being turned onto this problem, most states are seeing further increases rather than declines in opioid abuse and its consequences. As the problem grows, physicians, emergency rooms and other healthcare providers are feeling pressure to find effective treatments for pain management, one of the largest causes of the growing problem.

Though illegal drugs such as heroin play their part, this crisis is fuelled by prescription drugs. The prescription painkiller problem began in the 1990s, when pharmaceutical companies persuaded healthcare providers that they could prescribe opioid painkillers without risk of addiction. This proved to be untrue, as large numbers of patients began misusing the drugs. Today, an estimated 21–29 percent of patients prescribed opioids misuse them, with 8–12 percent developing a disorder. And while misuse of legal drugs is a huge problem in its own right, it is also the gateway to illegal opioids. However, by the time the problem was recognized, the medical sector had become reliant on opioids. Pain relief is a critical part of modern medicine, which helps patients manage chronic conditions as well as cope with recovery from shorter-term illnesses, accidents and operations. Simply abandoning opioids was not an option.

An Alternative to Opioids

One option gaining increased attention may be the use of all-natural cannabidiol (CBD) products, as a plant-derived option to the use of synthetic prescription painkillers. These products do not contain THC, the ingredient that gets cannabis users high, and so can be used to provide relief without impairing a user’s normal mental activities. Products containing CBD, which have recently been developed by companies such as Marijuana Company of America (OTC:MCOA) may offer a viable alternative to synthetic medicines.

CBD applications and uses have benefitted from changes surrounding that industry. Licenses  to grow industrial hemp have allowed companies to combine agriculture, R&D and product development with those seeking medical uses for hemp. MCOA’s recently established cultivation in Oregon is a prime example of this work, with researchers developing better growing techniques and improved plant strains that will allow them to extract higher yields of CBD oil.

A Healthier Option?

Scientific research into the effectiveness of CBD supports its potential in pain relief. A review of recent studies found that it was generally effective in helping patients manage their pain. Not only can it provide a viable alternative to opioid painkillers.

The advantage of CBD over opioids appear to be that it may provide a safer, healthier treatment option. CBD appears to be far less physically and mentally addictive than many prescribed pain medications. Patients can use it without experiencing the high risks of addiction that accompany many prescription painkillers.

The World Health Organization released a scientific research report conducted on CBD, which found the compound to be nonpsychoactive and nonaddictive; the report also noted that it has multiple health benefits. CBD oils provide patients with access to the relief that medical marijuana would bring but without many of the side effects.

Applied Medicine

By providing alternatives for relief, companies working with CBD are providing a pathway out of the opioid epidemic. One example of a CBD pain-management product is MCOA’s recently released hempSMART Pain Cream.

HempSMART Pain Cream is a topical treatment developed to reduce discomfort, support joint mobility, and relax muscles. Each bottle contains 300mg of full-spectrum CBD derived from industrial hemp, combined with other natural plant-based extracts. The cream contains the company’s own formulation of Ayurvedic herbs along with menthol, cayenne pepper extract, rosemary oil, aloe gel, white willow bark, arnica, wintergreen extract and tea tree oil. Together, these ingredients appear to provide an immediate cooling and soothing sensation, while the CBD helps to ease discomfort.

“We will continue to expand our health and wellness lines in 2018 to include more products,” said MCOA CEO Donald Steinberg. “Pain Cream has been enthusiastically received by our affiliates and customers.”

Pain Cream is just one of many hempSMART products already developed by MCOA. As more is learned about the potential uses of CBD in wellness products, the company will likely develop new products and treatments. From hempSMART Brain, a brain-enhancing formulation, to hempSMART Face, a CBD-infused cosmetic, the company is finding new ways to deliver the benefits of this chemical compound.

Cannabis Companies Explore Potential of CBD

Meanwhile, patients looking for pain relief have the chance to move away from prescription drugs and into treatments without the same risks of addiction. A number of other companies are also exploring the potential of CBD treatments.

One of the most prominent is Cronos Group, Inc. (NASDAQ:CRON), the first Nasdaq-traded company purely focused on cannabis. Though based in North America, the company has recently started branching out, obtaining a manufacturing license to produce products based on medical cannabis in Australia. Boosted by funds raised through a recent public offering, the company is set to become a global player in the field of cannabis-derived treatments, including pain medication.

Canopy Growth Corporation (NYSE:CGC) is also looking to bring cannabis and CBD treatments to a wider market. Having previously acquired a cannabis company in Lesotho, giving it access to the African market, the company is now expanding into Latin America through the acquisition of a Colombian company. Canopy Growth produces oils with varying levels of CBD to meet the varying needs of customers.

One of the world’s largest cannabis companies, Aurora Cannabis, Inc. (OTCQX:ACBFF) is heavily involved in pain relief through its wide selection of medical cannabis strains. The company recently took a step toward improving its research into cannabis-derived medicine, thanks to the Canadian Competition Bureau’s approval of a proposed takeover of MedReleaf. By acquiring another R&D-driven cannabis company, Aurora hopes to expand its own research into CBD-based medicines.

Medical cannabis company Organigram Holdings, Inc. (OTCQB:OGRMF) has produced a range of different strains, including CBD-rich options. It has recently been licensed to expand its production facilities, allowing the company to better meet the needs of a growing market.

With companies developing hemp-derived, CBD-based wellness products, a new alternative to synthetic opioid-based medications is emerging. CBD-based options may also provide access to the benefits of medical cannabis without that product’s mind-altering properties and other worrisome side effects.

For more information about Marijuana Company of America, please visit Marijuana Company of America (OTC:MCOA).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN

Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com

Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado

www.CannabisNewsWire.com
303.498.7722 Office

Editor@CannabisNewsWire.net

Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611 

Source:  CannabisNewsWire

.

 

Cannabidiol Market Anticipates Growth as Regulatory Change Looms in U.S.


New York, NY – July 10, 2018 – CannabisNewsWire.com News Coverage:  Restrictions in the United States on cannabidiol (CBD), an active ingredient in cannabis, appear likely to loosen over the next few months, creating opportunities for CBD production and distribution companies.

  • CBD is an active ingredient with medical benefits but no “high”, or pyshcoactive effects.

  • The Food and Drug Administration (FDA) has approved a CBD-based medicine for the first time.

  • Companies are cultivating hemp to develop high yielding CBD plants.
     

Marijuana Company of America, Inc. (OTC:MCOA) is cultivating industrial hemp for CBD  propagation at sites in the United States and Canada while continuting to develop and manfuacture CBD-based products for its hempSMART™ brand. Cronos Group, Inc. (NASDAQ:CRON) is expanding its global reach for cannabis products through deals covering the United States, Canada, Australia and Poland, as this sector of the economy goes global. CV Sciences, Inc. (OTC:CVSI) is providing a clean bill of health for its CBD wellness products. Terra Tech Corp. (OTC:TRTC) is providing advanced hydroponic growing systems that increase crop yields and reduce costs for CBD-oriented companies. Manufacturer Liberty Health Sciences (OTC:LHSIF) produces cannabis in facilities recently certified as meeting high standards for manufacturing.

FDA Leads the Way to Reclassify Cannabidiol

The market for cannabis and hemp products has seen a low-key but potentially huge step forward in recent weeks. For the first time, the FDA has approved a medicine that uses cannabidiol (CBD) as its active ingredient. CBD is a compound that can be found in the hemp and cannabis plants, but unlike tetrahydrocannabinol (THC) it does not get users high.

Repeated studies have demonstrated the beneficial effects of cannabinoids. As a result, cannabis products have been approved for medical use in many states, but this is the first time that a cannabinoid-based CBD product has been approved at the federal level. This approval represents a softening of the federal government’s attitude. CBD was previously classified as a Schedule I drug by the Drug Enforcement Agency, but this body is now expected to change its stance within the next three months, allowing the possibility to manufacture products that would currently be banned on the national level. This possibility represents a huge moment for the CBD industry.

Better Plants for Better Health

One of the companies likely to benefit from this change is the Marijuana Company of America, Inc. (OTC:MCOA). The company is focused on the cultivation of industrial hemp and the manufacturing of hemp-derived CBD products, and is expanding its operations to better serve its growing market.

The most recent addition to the company’s operations is an industrial hemp cultivation site in Scio, Oregon. Created in collaboration with Global Hemp Group (GHG), this is a 109-acre site in the Willamette Valley. With its rich soil and pre-existing irrigation infrastructure, the valley provides an ideal location for an agricultural project that has already been home to cannabis cultivation in the past.

The Scio facility uses a mixture of cultivation practices. It has 19,000 square feet of greenhouse growing space under construction alongside fields for outdoor crops. This will allow the company to produce a steady supply of hemp all year, with high-yield plants ensuring a significant volume of output.

One of the main aims of the team working at Scio is to encourage plant strains that have a particularly high yield of CBD. Careful data collection and analysis are being used to assess the quality of plants and the effectiveness of techniques used to grow them. The expected change in the legal status of CBD in the United States will make it easier for MCOA to conduct research and cultivate CBD rich industrial hemp like at the Scio site, and for patients to have access to the products that come from it.

Working with Government to Improve Agriculture

MCOA and GHG are also collaborating on a similar project in New Brunswick, Canada, on a much larger scale. For this project, the two companies are working with the New Brunswick Department of Aquaculture, Agriculture and Fisheries (DAAF) to explore better approaches to growing hemp.

With markets for hemp and CBD reaching greater maturity, the DAAF has shown its faith in the future by awarding a grant of $10,750 to the joint MCOA and GHG venture in the region. These funds will be used on test projects for the current crop season, which will allow the companies to improve their cultivation techniques.

These government-funded tests are focused on three areas, two of which are looking at soil conditions to identify the best levels of nitrogen fertilizer for crops and whether soil acidity can be effectively adjusted using local supplies of slag lime. The third area of study is the European corn borer, a moth that damages crops and that has been a pest to farmers in the region. Damage from borers was found on hemp stalks last year, so the companies will be looking at the impact this damage could have on cultivation.

The latest technology is being used to ensure the success of these tests. A drone company has been employed to provide overviews of growth across hemp fields because the height of the stalks and density of cultivation makes assessment by other means difficult. With agricultural experiments underway in both Canada and the United States, MCOA has multiple opportunities to cultivate better CBD crops.

In New Brunswick, the two companies have created what they refer to as the Hemp Agro-Industrial Zone (HAIZ), where they are carrying out trials of hemp cultivation targeted at developing the industry in the province. By exploring cultivation techniques, ensuring a market for the product and providing consistent jobs for local farm workers, they aim to create a green-industry cluster specializing in hemp.

Creating Wellness

MCOA isn’t just a cultivation company. It is manufacturing its hemp crops into a wide range of products formulated to improve the well-being of customers.

Much of this work is carried out through hempSMART, the company’s most prominent consumer brand. HempSMART creates CBD-based wellness products and provides consumers with education about the potential benefits CBD may provide. Many consumers don’t understand the difference between CBD and THC products. Through hempSMART, MCOA is raising awareness while reaching out to a growing market.

The most recent release from hempSMART is the relaunch of its hempSMART Brain product. This version doubles the dose of CBD from the original, combining CBD oil with a blend of natural plant-based ingredients. Designed to maintain mental clarity, alertness, focus and concentration, as well as promote relaxation, restorative sleep, and the repair and regeneration of brain cells, hempSMART Brain is a flagship product that demonstrates MCOA’s wellness agenda. With the prospect of a change in the CBD compound’s legal status in the United States, companies such as MCOA will have more opportunities to develop and sell these types of products, spreading CBD-based wellness.

Growing Companies Profit from Changing Regulations

A range of companies in the cannabinoid sector will be in a position to profit from this change. Cronos Group, Inc. (NASDAQ:CRON) is demonstrating the global potential of cannabinoid products. The North American company already has a cross-border deal that allows it to make use of advances in both Canada and the United States. In addition, Cronos was recently granted a manufacturing license to produce cannabis-based products in Australia, and a new Polish distribution agreement will give the company a foothold in the European market.

CV Sciences, Inc. (OTCQB:CVSI) is firmly focused on the CBD sector. The company has two parts: a drug development division exploring novel CBD-based treatments and a consumer product division that manufactures, markets and sells the resulting products.

Some companies are focused on providing support and equipment for CBD cultivation. Terra Tech, Corporation (OTC:QXTRTC) has created a hydroponic growing system that uses moving tables to increase yields by up to 30 percent while reducing costs by up to half. Its energy efficiency and recycling of waste water means that the company’s systems live up to the expectations of green-minded consumers.

Liberty Health Sciences (OTCQX:LHSIF) works in the medical cannabis market. As it acquires and operates U.S.-based cannabis companies, its aim is to produce safe, high-quality cannabis for patients. It has recently received Good Manufacturing Practice certification for its high standards of safety, consistency and quality.

Given the growing number of players in the cannabis market, a shift in the classification of CBD on a federal level could have a tremendous impact. For companies already focusing on CBD products, a huge opportunity for growth in the United States may be on the horizon.

For more information about Marijuana Company of America, please visit Marijuana Company of America, Inc. (OTC:MCOA).

About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com


Corporate Communications Contact:

CannabisNewsWire (CNW)
Denver, Colorado

www.CannabisNewsWire.com
303.498.7722 Office

Editor@CannabisNewsWire.net

 Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611

News Source: CannabisNewsWire

 

Farm Bill Legislation May Springboard Federal Hemp Acceptance


New York, NY – June 27, 2018 – CannabisNewsWire.com News Coverage:  The United States House passed the  2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a viable agricultural commodity. Through its hempSMART™ subsidiary, Marijuana Company of America, Inc. (OTC:MCOA) is one example of a few companies currently providing consumers hemp plant-based products under the rubric of existing laws, and the company has undertaken broad-based legal hemp cultivation programs. Other companies that could feel the ripples of change in the space are Isodiol International, Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F), CV Sciences, Inc. (OTC:CVSI), Medical Marijuana, Inc. (OTC:MJNA), and Lexaria Bioscience Corp. (CSE:LXX) (OTC:LXRP) (LXRP Profile).
Hemp’s History

Archaeological evidence reveals that for over 10,000 years hemp has been used by humans for pottery, shoes, ropes, clothing, food, medicine, and a wide array of other applications. Since early populations ingested hemp seeds, it stands to reason they also discovered the medicinal properties found in the plant. Ancient Asia, Egypt, India, Greece and the Islamic world all have rich histories relating to medicinal cannabis. In the 19th century, cannabinoids gained popularity for therapeutic use in Western medicine, but regulatory efforts imposed strictures during the 20th Century, eventually leading to a ban on its use in the U.S. under federal drug controls because of hemp’s relation to its more drug-user-friendly cannabis counterpart, marijuana. But, in recent years, society has turned to modern science to substantiate anecdotal claims about the therapeutic efficacy of non-psychoactive cannabidiol (CBD) found in the hemp plant.

"I know there are farming communities all over the country who are interested in this," McConnell told the Senate Agriculture Committee amid debate over his bill. "Mine are particularly interested in it, and the reason for that is — as all of you know — our No. 1 cash crop used to be something that's really not good for you: tobacco. And that has declined significantly, as it should, given the public health concerns.”

The federal government has exhibited schizophrenic regulatory tendencies toward hemp since the passage of the Marijuana Tax Act of 1937 that quashed hemp production with exorbitant excise taxes.  Reversing course during WWII, the government urged farmers to grow hemp for fiber and also waived taxes, and over 400,000 acres of hemp were cultivated between 1942 and 1945. After the war, hemp again had persona non grata status. Congress then passed the Controlled Substances Act in 1970, prohibiting the use of all cannabis for any purpose whatsoever and eff
ectively terminating all industrial hemp production. Hemp extracts, however, are considered legal because they contain less than 0.3 percent THC, but the cultivation of hemp remains federally verboten. Now, the advancement of the Farm Bill signals a revived federal interest in the industrial hemp industry.

Hemp Pioneers

Led by hemp industry pioneers, Marijuana Company of America, Inc. (OTC:MCOA) has spearheaded efforts and staked claims on multiple legal hemp cultivation projects. The company’s innovative strategy is to vertically integrate hemp production and sales – from seed to shelf. Cultivation of quality hemp will feed MCOA’s innovative CBD-based formulations, which use the highest-quality hemp
to produce what could be the finest-quality botanical supplements on the market. The hempSMART™ product line contains tested levels of clinically researched ingredients to meet consumer needs that support the body’s natural endocannabinoid system.

From seed to shelf, MCOA has built its business model around industrial hemp-based CBD products. Hemp has
a myriad of uses beyond CBD therapeutics – as a food, a natural fiber, and even as a commodity in the building materials sectors. No part of the plant goes unused, and MCOA’s overarching strategy is to capitalize at each profit point – from farm to finished products. MCOA appears to be establishing a commanding presence at multiple inflection points across the entire hemp value chain.

hempSMART™, Inc.

Expanding on ancestral wisdom, MCOA has combined the most effective ingredients in wellness technologies with pure plant-derived industrial hemp-based cannabinoids to create optimally formulated wellness products for health-conscious consumers.

hempSMART™ offers a number of different products within a wide range of delivery systems, such as its capsule-based formulations hempSMART™ Brain, a patent-pending nootropic product designed to support natural brain function; and hempSMART™ Pain, which is formulated with a blend of premium full-spectrum CBD and botanical supplements designed for pain associated with physical activity.

The company also offers sublingual CBD tinctures to customers including hempSMART™ Full-Spectrum Drops and their natural pet supplement hempSMART™ Pet Drops with advanced bioavailability.

hempSMART™ has also expanded upon its established line of products by offering topical products such as hempSMART™ Pain Cream, which is designed to provide temporary relief and soothe sore, aching muscles and joints. The company also launched a new cosmetic product, hempSMART™ Face, a CBD facial moisturizer that has been designed to refresh, replenish and restore skin cells on the face.

MCOA’s hempSMART™ CBD consumer products are sold at www.hempsmart.com.

Hemp Cultivation

In what appears to be a vertically integrated business strategy, MCOA entered into a joint venture with Global Hemp Group Inc. (OTC: GBHPF) to launch multiple industrial hemp cultivation projects in the legal marijuana states of the U.S. and in Canada. The first is a 125-acre industrial hemp cultivation project in northeast New Brunswick. The project is well under way with objectives of promoting hemp farming and attendant year-round jobs.

A certified professional agronomist, Joan Parker-Duivenvoorden, has been hired to manage the project. She has over 15 years of experience with the Nova Scotia Department of Agriculture and with the New Brunswick Soil and Crop Improvement Association, which will prove invaluable as the project expands to encompass and employ over 50 farmers.

Planting has been completed on the first 77 acres, and the remaining 48 acres will be seeded soon. Drying equipment is being evaluated to process the hemp after harvest, and management is already in discussions with several potential processing partners for extraction of cannabinoids. Once all the licenses have been acquired for importing and manufacturing finished CBD products, the New Brunswick site could easily serve as a distribution center for MCOA’s hempSMART™ subsidiary.

In another joint venture with Global Hemp Group, MCOA is also developing Covered Bridge Acres, a high-yielding CBD hemp cultivation project in Oregon. Operations at the farm are well under way. The project will utilize both traditional outdoor cultivation and what will be over 19,296 square feet of greenhouses.

“Our evolving project in Scio, Oregon, highlights the quality of the team in place as they continue to lean on their many years of experience cultivating hemp. Activities such as these will help to secure the raw oil that we will need for our hempSMART brand of CBD infused products,” stated Donald Steinberg, MCOA’s CEO.

The Takeaway

With rapidly expanding retail distribution and burgeoning, diversified hemp cultivation programs underway, MCOA is fast approaching the vertical integration that typically impacts bottom lines and drives shareholder value.

Other companies already operating in the CBD space include:

Isodiol International (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) grows and harvests hemp on an industrial scale and then processes it to extract cannabidiol (CBD) for worldwide distribution. The company pioneered the commercialization of 99 percent-plus pure, pharmaceutical-grade cannabinoids, micro-encapsulations and nanotechnology for consumable and topical skin care products.

CV Sciences (OTC:CVSI) operates in two business segments. The company’s drug development division develops and commercializes novel therapeutics utilizing synthetic CBD. Its consumer product division manufactures, markets and sells plant-based CBD products to a range of market sectors.

Medical Marijuana (OTC:MJNA) develops, distributes and sells hemp oil that contains naturally occurring cannabinoids, including CBD, and other products containing CBD oil. The company sells its hemp-derived CBD products through its distribution subsidiaries. The company was among the first to bring hemp-based CBD oil products to market in the United States.

Lexaria Bioscience Corp. (CSE:LXX) (OTC:LXRP) out-licenses its patented delivery technology, which lowers dosing of lipophilic active molecules and enhances their effectiveness. The company’s technology increases intestinal absorption rates, speeds delivery to the bloodstream, and masks tastes for orally administered bioactive molecules including cannabinoids, vitamins, NSAIDs, nicotine and other molecules.

Together, MCOAand these companies weave a tapestry of industry, innovation and intuitive concern for the communities they serve with nature-based hemp products that appear to be once again losing the stigma that has come from being marijuana’s staider sibling.

For more information on Marijuana Company of America, visit:
Marijuana Company of America, Inc. (OTC:MCOA).
           

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.


CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN

Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com

Corporate Communications Contact:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611


Source: 
CannabisNewsWire

.

 

 

Dangers Lurking in Synthetic CBD Underscore Value of Quality Product


New York, NY – June 20, 2018 – CannabisNewsWire.com News Coverage:  Dating back thousands of years, people have found ways to treat pain and other ailments with cannabidiol (CBD) oil which is harvested from the hemp plant. However, the natural healing properties of CBD are being jeopardized by the advent of man-made synthetic CBDs. These chemical analogs are dangerous imitations of plant-derived product, binding to human endocannabinoid receptors at astronomically larger quantities than natural cannabinoids. These designer drugs prompted the U.S. Centers for Disease Control and Prevention to issue a national health alert warning about synthetic cannabinoids. Shunning synthetics, Marijuana Company of America, Inc. (OTC:MCOA) provides consumers complete transparency and delivering only pure, plant-based 100% hemp-derived products through its hempSMART™ brand. While Medical Marijuana, Inc. (OTC:MJNA) and PotNetwork Holding, Inc. (OTC:POTN) market hemp-derived CBD products, some companies such as Isodiol International, Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) and CV Sciences, Inc. (OTC:CVSI) utilize extraction techniques to produce isolated cannabinoid compounds for both commercial and/or research uses.

Surging Demand Creates Copy Cats

Hemp-derived CBD grew from a market category that didn’t exist five years ago to generating $190 million in sales in 2017. The U.S. industry is poised to reach $1 billion dollars in 2018, led by hemp-derived CBD, food, personal care and industrial products. Hemp Business Journal estimates the U.S. hemp industry will grow to a $2.6 billion market by 2022 with an estimated five-year CAGR of 25%.

In a recent article, “Fighting fakes: Hemp leaders on the dangers of synthetic CBD,” public health investigators issued warnings when 50 people were sickened after consuming synthetic CBD. What the epidemiologists found was that the products, while labeled CBD, did not contain CBD compounds. Instead, the products contained a synthetically produced cannabinoid.

CBD products are often mislabeled, both in how much CBD the products contain and where the CBD comes from. A study published in JAMA revealed that nearly 70% of online CBD marijuana extracts are mislabeled, some had extra CBD, some less, and some contained hidden CBDs. Blind testing found that only about 31% of the extracts tested contained the amount of CBD listed on the label.

Differentiated from Others

The company’s commitment to quality may differentiate
Marijuana Company of America, Inc. (OTCPK:MCOA) from all others in the sector. MCOA uses the highest-quality sourced raw materials to produce the finest quality botanical supplements and topicals on the market. To ensure quality and transparency, the company’s hempSMART™ product line has been rigorously tested to validate its purity. Products developed by hempSMART are derived and formulated from industrial hemp containing naturally occurring CBD compounds that help support the body’s natural endocannabinoid system. All hempSMART™ products contain tested levels and clinically researched ingredients designed to meet and exceed consumers expectations.

The company is led by cannabis industry pioneer Donald Steinberg, MCOA’s CEO and an experienced vete
ran of the cannabis and industrial hemp industries. Steinberg founded the first marijuana company ever to trade on a U.S. stock market, and his extensive background and knowledge of the industry may give the company unparalleled insights into the global industrial hemp and cannabis markets.

Celebrated Family of Products

Derived from industrial hemp containing CBD compounds, MCOA’s hempSMART™ product line is among the finest quality of botanical supplements on the market. Scientifically driven, each of MCOA’s hempSMART™ products are created to ensure only the highest quality products reach discerning consumers. MCOA’s hempSMART™ CBD consumer products are researched, developed and sold at www.hempsmart.com.

The company recently re-launched its patent-pending wellness nootropic product hempSMART™ Brain, a “first of its kind” researched formulation for optimal brain function support, with 300mg of full spectrum CBD per bottle. HempSMART products also include full spectrum bioavailable CBD drops in form of a tincture containing a high concentration and potency of CBD, hempSMART ™ Pain capsules with a blend of premium CBD and botanical supplements, and hempSMART ™ Pain Cream with a synergistic combination of natural botanicals and full spectrum hemp extract to treat aching muscles and joints. In addition, the company now provides hempSMART™ Full Spectrum Pet Drops, exclusively designed for fur-bearing family members.

To virally expand sales, MCOA created its own unique hempSMART affiliate network marketing program. The affiliate marketing program provides a generous compensation plan to promote and sell hempSMART’s CBD consumer products in the United States. Advocates of hempSMART’s CBD products make the best ambassadors and the sales model lends itself to rapid global expansion.

Diversified Opportunity

In addition to the research and development of hemp-based consumer products, MCOA is strategically expanding its footprint across multiple facets of the hemp industry, building a portfolio of diversified investments and joint ventures to grow the company and potentially drive shareholder value.

The company recently provided updates on its 125-acre industrial hemp cultivation project in northeast New Brunswick with joint-venture partner Global Hemp Group Inc.  Planting on the first 77 acres is complete and the remaining 48 acres will be seeded soon. Drying equipment is being evaluated to process the biomass after harvest and management is in discussions with several potential processing partners for the material.

To target impulse buys in high traffic convenience stores, MCOA secured a 25% equity stake in Convenient Hemp Mart, LLC’s BeniHemp branded products. BeniHemp products will include topicals, tinctures, and edibles packaged in one-day, two-day, and 30-day supplies distributed to convenience stores, smoke shops, gas stations and similar small retail businesses.

Each owning 42.5%, MCOA and Global Hemp Group formed a joint venture, Covered Bridge Acres LTD., to develop a high yielding CBD hemp cultivation project in Oregon and committed to jointly invest a total of US$1.2 million into the project. A cornerstone of the project is the acquisition of a 109-acre agricultural property in Scio, Oregon. The property, located 70 miles south of Portland, is situated in the fertile Willamette Valley and has a history of hemp cultivation over the past two years. The farm is ideal for cultivating hemp as it contains a high level of organic matter in the soil and has an established irrigation infrastructure with sufficient water rights.

MCOA successfully raised $1 million in funding for Bougainville Ventures to construct and manage a turnkey state of the art cannabis cultivation and processing facility. The joint venture has completed the setup of 10,000 sq. ft. of greenhouse space and waiting for completion of inspection, the final step before commencing cultivation.

Active Companies Vying for Market Position

CV Sciences (OTCQB:CVSI) operates two business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing naturally occurring CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company recently announced the June 7, 2018, publication of the toxicology and safety results of an extract from the base raw materials used in its PlusCBD Oil™ consumer products. The study, designed to investigate the safety of oral consumption of the company’s hemp CBD oil and to support a Generally Recognized as Safe (GRAS) Independent Conclusion, concluded that the test article was non-mutagenic, non-clastogenic and non-genotoxic.

Isodiol International (CSE:ISOL) (OTCPK:ISOLF) (FSE:LB6A.F) is focused on pharmaceutical grade phytochemical compounds and is among industry leaders in the manufacture and development of consumer products. The company pioneered the commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for consumable and topical skin care products. Isodiol earlier this month entered into a binding agreement to acquire 51% of Round Mountain Technologies, LLC (“RMT”), a cultivator of organic hemp with operations in Nevada.

Medical Marijuana (OTCPK:MJNA), the first publicly traded cannabis company in the United States (founded by current CEO of Marijuana Company of America Don Steinberg), develops, distribute and sells hemp oil that contains naturally occurring cannabinoids, including CBD and other products containing CBD oil. In recent news, MJNA announced its favor on the Drug Enforcement Administration’s (DEA) recent statement on the legality of CBD -- which further clarifies that some CBD products, such as hemp-derived CBD products, are legal to distribute throughout the United States and do not fall under the regulations of the Controlled Substances Act (CSA). Additionally, the company’s HempMeds® subsidiary reported the historic authorization of its Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil product for import into Argentina.

PotNetwork Holding (OTCPK: POTN) is a holding company for its subsidiaries, First Capital Venture Co. that owns Diamond CBD, Inc., the maker of Diamond CBD oils. Diamond CBD researches, develops and markets hemp extracts that contain a broad range of cannabinoids and hemp derivatives. The company recently announced that Diamond CBD’s online sales increased 639% higher than the year prior. PotNetwork is in currently preparing to file with the SEC to become a fully reporting company.

With an estimated 25% compound annual growth rate, there’s little doubt the about the trajectory of the CBD market. As the market continues its rapid expansion and more people become aware of the dangers lurking in synthetic CBD, it seems reasonable that evermore consumers will gravitate toward high-quality natural CBD product. Companies like MCOA aim to answer that call.

For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC:MCOA)

About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer


DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.


Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com


Corporate Communications Contact:

CannabisNewsWire (CNW)

Denver, Colorado

www.CannabisNewsWire.com

303.498.7722 Office

Editor@CannabisNewsWire.net

 

Media Contact:

FN Media Group, LLC

NNW@FinancialNewsMedia.com  

+1-(954)345-0611

  

News Source: CannabisNewsWire

 

MARIJUANA COMPANY OF AMERICA LAUNCHES NEW CBD INFUSED COSMETIC PRODUCT HEMPSMART FACE


ESCONDIDO, CA -- June 19, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to announce that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product hempSMART™ Face.

Each bottle of hempSMART™ Face is formulated with 150mg of full spectrum, non-pyschoactive, Cannabidiol (CBD) oil derived from the industrial hemp plant. The newly developed hempSMART™ topical is a nourishing facial moisturizer that combines CBD oil with a unique blend of ayurvedic herbs and botanicals that is designed to refresh, replenish, and restore your skin cells on your face.

The innovative new formula is rich in Omega 3, 6, 7 and 9, along with naturally occurring ceramides and contains synergistic ingredients such as Organic Aloe, Sabi Inchi Oil, Argan Kernel Oil, Macademia Seed Oil, Rose Hip Seed Oil, Pomegranate Seed Oil, Tulsi, Turmeric Oil, Frankinsense, Ashwaganda, Sweet Potato Root Extract, Coconut Oil, and Sea Buckthorn Oil.

MCOA’s CEO Donald Steinberg commented, “Our team is excited to announce the expansion of the hempSMART™ brand into the world of cosmetic products. HempSMART™ will continue to build upon our already established and unique formulations to provide our customers and affiliates with the tools needed to succeed in the wellness industry.”

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

SOURCE:  Marijuana Company of America, Inc.


Government Interest in Hemp Diversity Signals Strong Future for American Cannabis Industry


New York, NY – June 13, 2018 – CannabisNewsWire.com News Coverage:  Recent U.S. government interest in ensuring industrial hemp supply signals a period of growth for the cannabinoid industry. Marijuana Company of America (OTC: MCOA) (OTC:MCOA) is contributing to this growth through new hemp cultivation projects in both Canada and the U.S., to support its hempSMART subsidiary. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) is benefiting from a cross-border venture that gives it access to new scientific advances and has seen its shares reach top exchanges. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has secured government licensing needed to become one of Canada’s leading retailers, while acquiring a subsidiary company in Lesotho to cater to an international market. Aurora Cannabis Inc. (TSX: ACB) (OTC: ACBFF) has announced a new range of products that provide medical cannabis with a high concentration of active ingredients. OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF) has struck a deal for access to advanced extraction technology, while also gaining a license to export its products to Australia.

Senate Signals Support for Cannabis Seedbank

The United States government has a complicated relationship with cannabis. Since the mid-20th Century, it has clamped down on the use of the plant for any purpose, particularly during the “war on drugs” from the 1980s onward. Over the past decade, some states have legalized the farming and sale of the cannabis sativa plant either as medicine, as a recreational drug, or in the form of industrial hemp. But the federal government has remained reticent about shifting its stance.

It seems that perceptions are now changing. The Senate Appropriations Committee, one of the most powerful bodies in government, has acknowledged the growing importance of industrial hemp for American farmers and called for the creation of a hemp seed back. Half a million dollars will be spent ensuring that America has a genetically strong stock of high quality hemp seeds, to support both farmers and researchers.

Building Better Strains

While the committee’s plan to build up seed stocks is intended to support the national interest, some companies are already working on improving industrial hemp growth for reasons of self-interest. Developing a diverse range of strains, each tailored to different purposes, is important for these companies. Industrial hemp is often valued for the quality of its fibres and the medicinal cannabinoids that can be extracted from the plant and implementing better growing techniques can lead to improved crops yields.

Among the companies looking to create more efficient hemp yields is the Marijuana Company of America (OTC: MCOA) (
OTC:MCOA). A company with a diverse portfolio of investments and joint ventures in the cannabis and industrial hemp sectors, MCOA is involved in several projects intended to improve the plants available to producers and consumers.

Together with the Global Hemp Group, MCOA has launched a
project to encourage industrial hemp cultivation in New Brunswick. Previous attempts to develop the industry in the region failed twenty years ago, but now the market for the product has grown. The aim is to develop an industrial cluster around the hemp crop, ensuring a market for farmers, consistent job opportunities, and to implement the proper structure to develop Hemp Agro-Industrial Zones, or HAIZ,
projects in other areas.

Scientific testing to improve the growing process is an important part of HAIZ. This has been made possible through cooperation with the Canadian government’s Department of Aquaculture Agriculture and Fisheries (DAAF). The department will be contributing fertilizers to the project and carrying out fertility trials on reserved plots of land. Together with soil testing and crop rotation, this will help to develop more fertile organic growing conditions for the hemp.


With legalization of the extraction of cannabinoids from industrial hemp on the horizon, Canada is an important market for cannabinoid-based companies. Recreational use alone is expected to
contribute $900 million to the industry, which already serves medical users in Canada. The work in New Brunswick gives MCOA an important foothold in this market.

More Facilities for a Growing Market

The collaboration with GHG is now taking place on both sides of the border, thanks to the establishment of a
new industrial hemp project in Scio, Oregon. Once again, the companies are collaborating to create a facility that will push forward techniques in hemp cultivation while providing a steady profit.

The heart of this operation is a 109-acre property in the Willamette Valley, a fertile area with a recent history of successful cannabis cultivation. The site has soil rich in organic matter and established irrigation infrastructure, meaning that it is well set to support a new agricultural project. The use of high yield hemp clones will help to maximise the output of the project.

Multiple approaches to cultivation will feed into the Scio facility’s output. Traditional outdoor cultivation will take place alongside five greenhouses, which will provide over 19,000 square feet of indoor growing space. This will ensure a year-round supply of hemp.

As in New Brunswick,
data collection and analysis will play an important part at the farm in Oregon. By checking on the performance of the growing techniques and the quality of the plants, the companies aim to support strains which are rich in cannabidiol (CBD), an active ingredient important in derivative products designed to support well-being.

A Growing Global Industry

The new project comes at a perfect time for MCOA. Demand for CBD is high thanks to the growing global market for cannabinoidbased products. A facility that can provide the companies with a steady supply of high-quality CBD plants will make it easier to take a substantial place in this expanding sector.

One of MCOA’s most important subsidiaries is hempSMART. This company develops and markets hemp-based wellness products that make use of cannabinoids, the active compounds that can be extracted from the hemp plant. HempSMART also aims to educate consumers on the possibilities offered by hemp, possibilities that the U.S. senate has started to acknowledge through its establishment of the new seed bank. Educators and health professionals are among the experts hempSMART has brought into its team, to make it more than just a source of wellness products.

With investments in everything from
payment systems to cultivation facility rentals, Marijuana Company of America has built a broad base of innovative cannabis-related products.

More Companies Signal Strong Future

It’s a sign of the health of cannabis industry that MCOA faces competition from a number of companies, both in hemp production and in the wider cannabis market.

Cronos Group, Inc. (TSX: CRON) (NASDAQ: CRON) is one of the highest profile companies in this sector. In February 2018, it became the first pure play cannabis company traded on the Nasdaq, a sign of the interest in cannabis by mainstream investors. A recent upgrade of its shares on the Toronto Stock Exchange reflects the way that cannabis companies are solidifying their position, proving that they are here to stay. A recently announced cross-border venture with MedMen means that Cronos will benefit from scientific advances being made by the Los Angeles company, which prides itself on its research work.

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is becoming a leader in the cannabis retail field. Within Canada, it has established itself as a trusted company, being granted one of the first retail licences in the province of Manitoba. This gives Canopy a strong starting point to sell to customers when recreational cannabis becomes legal in Canada later this year. Further afield, it recently acquired a cannabis company in the Kingdom of Lesotho. This will provide access to an African market largely ignored by western cannabis companies. It will also let the company grow medical cannabis in ideal conditions, with 300 days of sunshine a year, excellent humidity, and great growing conditions for greenhouse grown cannabis.

One of the largest cannabis
companies, Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) has recently expanded its activities to cover both the recreational and medical sectors. The company leans heavily on research to improve its sales, with the announcement in late May of a new range of high-THC content cannabis products. It has also made moves to expand its market reach over recent months, with the largest corporate acquisition in the history of the cannabis industry in the form of the purchase of CanniMed, as well as a supplier agreement with Shoppers Drug Mart.

OrganiGram Holdings Inc. (TSX-V: OGI) (OTCQB: OGRMF) is looking beyond the American market. The company has recently been granted a license to export cannabis to Australia. This will introduce OrganiGram’s product to a new territory through a deal with a licensed Australian medical cannabis dealer. Organigram’s success will be further bolstered by a recent deal with TGS Colorado, a company with expertise in extract technology. This will provide Organigram with access to best-in-class technologies, products, and designs with which to make the most of its expanding cultivation base.

Increasing government backing, combined with advances in cultivation and technology, ensures that there’s a healthy future for all varieties of cannabis, from medical marijuana to industrial hemp.

For more information about Marijuana Company of America, please visit Marijuana Company of America (OTC: MCOA) (
OTC:MCOA)

About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.


Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com


Corporate Communications Contact:

CannabisNewsWire (CNW)
Denver, Colorado

www.CannabisNewsWire.com
303.498.7722 Office

Editor@CannabisNewsWire.net

 Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611

News Source: CannabisNewsWire

 

Diversity Leads to Growth in Flourishing Cannabinoid Industries


New York, NY – June 7, 2018 – CannabisNewsWire.com News Coverage:  The cannabis industry is about more than medicine and recreational drugs. Whether selling hemp-derived textile and construction products or providing resources to support cannabis growers, companies are now accessing the market in a variety of ways. Marijuana Company of America Inc. (OTC:MCOA) is developing hemp-based wellness products and cultivating industrial hemp on a large scale in Canada and the United States. Scotts Miracle-Gro Company (NYSE:SMG) is selling hydroponic equipment to legal cannabis growers and has recently made a significant acquisition in this area. Cronos Group, Inc. (TSX:CRON) (NASDAQ:CRON) has used its success to become the first pure play cannabis company traded on Wall Street and in Canada was uplisted to reach the Toronto Stock Exchange. PotNetwork Holding, Inc. (OTC:POTN) has fostered a range of subsidiaries whose diverse products include cannabinoid wellness products. In addition, companies such as AbbVie, Inc. (NYSE:ABBV), which already has a cannabis-based drug on the market, may be ahead of the game as the industry expands and evolves moving forward.

A Diverse Industry

A lot of attention is currently on the medical and recreational potential of the cannabis industry. The huge sums of money already spent on the life-changing promise of medical marijuana have pushed these areas to center stage. But while they are undoubtedly an important part of the sector, they do not illustrate the whole picture involving industrial hemp’s nationwide come back.

Much of the growth in the hemp industry is in subsidiary services and other uses for the plant’s products. Hemp –
a variety of cannabis that does not contain its siblings’ intoxicating potential – is being grown for use in food, fibers and even building materials, all without getting anyone high. Landlords, compost manufacturers and engineering companies are finding ways to support and profit from the changing market. Even research into active ingredients involving cannabinoids is shifting away from THC, the chemical that gets marijuana users high, and toward the potential uses of non-intoxicating cannabidiol (CBD), which can be obtained from hemp.

The result is a varied industry in which companies can flourish through variety instead of focusing on one sphere.

Careful Cultivation

Marijuana Company of America (OTC: MCOA) is making the most of this opportunity. Founded by two veterans of the cannabis industry, MCOA is building a portfolio of partnered companies working across the sector.

One of the company’s important assets is hempSMART™, a wholly-owned subsidiary of MCOA. The hempSMART brand is focused on producing and marketing wellness products including CBD derived from hemp. The hempSMART team makes use of the cannabinoid chemicals to provide a range of products that are useful and appealing to consumers.

Hemp products were worth at least $688 million in 2016 and are expected to be worth $1.8 billion by 2020. Ownership of hempSMART gives MCOA a place in this significant part of the sector, meaning that it is not dependent on federally illegal THC-laden cannabis products to grow and sustain its revenue streams.

As a newly emerging industry, cannabis faces a great deal of uncertainty over sales and income potential. This uncertainty creates investor opportunities as companies outperform expectations. But it also creates risks due to fluctuations in income. A cultivation project in Washington State is providing MCOA with a buffer against these risks.

Created as part of a joint venture with Bougainville Ventures Inc., the cannabis cultivation and processing facility at Oroville, Wash., covers 10,000 square feet of state-of-the-art growing space, which will eventually be expanded to 30,000 square feet. Rather than using the site to grow its own products, MCOA is renting out the facility to a growing company, which is expected to begin work there this month. The rent from the facility ensures a stable source of income for MCOA — derived from cannabis cultivation but not prone to its uncertainties. By providing this facility, the company is also supporting the growth of the cannabis sector, creating a market for such properties and for its own related products.

Preparing for the Canadian Market

Making the most of the possibilities offered by cannabis isn’t just about diverse products, it’s also about diverse markets. For any company working in North America, Canada is one of the most important markets currently and MCOA is preparing to enter that market.

Canada is already a significant market for industrial hemp-derived products and medicinal cannabinoids. Legislation due to come into force later this year will legalize the extraction of cannabinoids for all potential uses which will make Canada one of the largest markets for legal cannabinoids in the world.

To make the most of this expected market growth, MCOA recently entered into a joint venture with Global Hemp Group, a Canadian company, to develop high-yield CBD hemp. Working on a 109-acre agricultural property in Scio, Oregon, the companies will use a dual-cultivation strategy with traditional outdoor cultivation alongside the year-round harvesting made possible by greenhouses. Cultivation of plants has already begun, and work has started to construct five new greenhouses to ensure substantial year-round growing capacity.

The project team will be using data collection and analysis to check the performance of growing techniques and to develop hemp rich in CBD. This will help to ensure supplies of high-grade hemp for both companies’ products.

“Our evolving project in Scio, Ore., highlights the quality of the team in place as they continue to lean on their many years of experience cultivating hemp,” said Donald Steinberg, the CEO of Marijuana Company of America. “Activities such as these will help to secure the raw oil that we will need for our hempSMART brand of CBD infused products.”

Meeting Growing Demand

The Oregon facility is coming into play at a perfect time for MCOA. Demand for CBD is high due to the increasing number of manufacturers and products on the market. This is creating a shortage of high-quality CBD.

MCOA’s new farm will provide an ample source of hemp-derived CBD. With its tie-in to the Canadian industry, the company looks to be in a strong position to profit from the shortage in both the American and Canadian markets. MCOA seems to have placed itself as the right business at the right time to make the most of a shifting market.

With its range of facilities and partnerships, MCOA has already developed a broad hemp-related portfolio. By incorporating elements that are protected from market uncertainties alongside ones better positioned to make the most of change, the company may be on track to make the most of changes in the sector.

More Companies Target Cannabis

Plenty of other companies are also building their hopes of tapping into the same markets as MCOA.

A growing interest in growing things means cannabis is creating opportunities for companies already established in the agriculture and gardening sectors. Scotts Miracle-Gro Company (NYSE: SMG) has agreed to acquire Sunlight Supply, the United States’ leading distributor of hydroponics products, for $450 million in cash and stocks. The company’s largest-ever transaction will double its sales to cannabis growers, turning the lawn and gardening company into an important supplier to the medical and recreational drug sectors. Though hydroponics are used for other specialist plant-growing purposes, legalized cannabis is a critical new part of the market.

The increasing importance of the cannabis industry was heralded when Cronos Group, Inc. (TSX: CRON) (NASDAQ: CRON) became the first pure-play cannabis company traded on Wall Street. A major grower and seller of cannabis products, the Canadian company is set to profit from the growth of the industry in its native country. In a further sign of its healthy prospects, its shares in Canada were recently upgraded from the Toronto Venture Exchange to the Toronto Stock Exchange. Like MCOA, it is working across North America thanks to a cross-border venture with Los Angeles-based MedMen.

Others are using a similar model to MCOA, investing in a range of cannabis companies. PotNetwork Holding, Inc. (OTC: POTN) has developed a range of subsidiaries that contribute to an increasingly diverse industry. Its Diamond CBD, Inc. subsidiary is reaching into the $110 billion global pet care industry by creating CBD-based wellness products for pets.

Finally, traditional pharma AbbVie, Inc. (NYSE: ABBV) seems to be positioning itself in the industry so it can take advantage of potential future growth and opportunities. The company already has a cannabis-based drug on the U.S. market. FDA-approved Marinol helps alleviate nausea or vomiting for chemotherapy patients, as well as helping AIDS patients who have lost their desire to eat.

From hydroponics to pet health and beyond, hemp-based cannabinoids are reaching into all corners of the economy and returning corporate profits.

For more information about Marijuana Company of America, please visit Marijuana Company of America (OTC: MCOA).

About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list
of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com

Corporate Communications Contact:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
 

Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611 

News Source: CannabisNewsWire

 

MARIJUANA COMPANY OF AMERICA ANNOUNCES THE RELAUNCH OF ITS REFORMULATED PATENT PENDING CBD PRODUCT HEMPSMART™ BRAIN


ESCONDIDO, CA -- June 5, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s hempSMART™ brand has relaunched its flagship wellness product hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving.

hempSMART Brain has been relaunched and redesigned with an improved formulation that includes 300mg per bottle of Full Spectrum, non-psychoactive, water soluble CBD oil per serving and contains a botanical blend of all-natural plant-based ingredients such as Ashwaganda, Fulvic Acid, Rhodiola Rosea Extract, Bacopa, L-Theanine, Green Tea Extract, and Huperzia Serrata.

hempSMART Brain has been developed to maintain mental clarity, alertness, focus and concentration as well as promote relaxation, restorative sleep, and support the repair and regeneration of brain cells, better known as neurogenesis. This unique formula promises to revolutionize the safe, effective, and natural optimization of brain wellness.

MCOA’s CEO Donald Steinberg stated, “After reviewing our hempSMART Brain product, our formulators chose to improve upon the original product by doubling the original dosage of CBD. Our team is proud to be able to welcome our flagship product back onto the market and look forward to the upcoming marketing campaigns.”

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART™ Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Source:  Marijuana Company of America, Inc.

 

CBD Market Set for Huge Growth


New York, NY – May 31, 2018 – CannabisNewsWire.com News Coverage:  In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC:MCOA), whose hempSMART™ brand will be among the first CBD products to be marketed on a mass national TV commercial. Growth in hemp-based products is only a piece of the cannabis industry puzzle. The entire legal cannabis industry is expected to hit $57 billion by 2027, with recreational marijuana use making up 67 percent of that and medical marijuana use taking up the remaining 33 percent. Other companies positioning themselves to take advantage of this incredible growth include AbbVie, Inc. (NYSE:ABBV), CV Sciences, Inc. (OTC:CVSI), KushCo Holdings, Inc. (OTC:KSHB), and Aurora Cannabis, Inc (OTC:ACBFF).

Capitalizing on the Power of CBD


Studies show that cannabidiol (CBD) possesses an array of therapeutic benefits, including antioxidant and neuroprotective properties. One of more than 85 cannabinoids identified in marijuana and hemp, CBD is typically used for health reasons and, unlike the more widely recognized compound tetrahydrocannabinol (THC), is not psychoactive, meaning it doesn’t cause a high. CBD products can be derived from industrial hemp plants or marijuana plants.


Marijuana Company of America (OTC:MCOA), an industrial hemp company, has capitalized on the power of CBD through its product research and development of legal hemp-based consumer products under the hempSMART brand, which targets general health and well-being. The products, which include drops and creams, are formulated to produce the finest botanical supplements on the market, derived from industrial hemp containing CBD compounds that help support the bodies endocannabinoid system.

A National Market Strategy and TV Commercial


Earlier this month, MCOA announced (http://cnw.fm/WxIg1) that it had engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television ad campaign to promote its hempSMART product line. Initially, hempSMART will be working with Verve Integrative to develop a market strategy and television commercial for its hempSMART Full Spectrum Pet Drops, which will air on cable networks this summer. The commercial spot will have featured placement on the official ecommerce site of a popular direct-response TV company and will be broadly promoted on integrated social media outlets.

“We are very pleased to partner with hempSMART on their journey to bring such thoughtful and well-developed products to the people who need natural relief and enhanced health solutions. I wish hempSMART™ Pet Drops were
available to support my cherished dog when we were going through a health challenge together,” said Castle, who, along with her team, bring more than 25 years of experience in many variations of media strategy, development and production. Their clients include Disney, GM, ABC, Paramount, and Grey Group.

The team specializes in multipoint story experiences designed to educate, entertain and endorse while mirroring the
human mind’s process of solving a problem, thereby supporting consumers in making emotional and logical product conclusions. Castle’s experience provides an invaluable edge to the hempSMART marketing campaign. Castle has also been an outspoken advocate of CBD as an alternative to traditional products currently on the market.

MCOA
CEO Donald Steinberg noted that “Kim’s experience gives us an excellent opportunity to greatly expand the marketing strategy for the hempSMART brand and product line. We are honored that the hempSMART product line will be managed by her and the Verve Integrative team. We look forward to the new television commercial airing this summer.”

Pet Supplement Market Expanding

MCOA
just launched its hempSMART Full Spectrum Pet Drops in February. The new specially formulated product contains naturally occurring CBD derived from hemp seed oil, full spectrum hemp extract, and fractionated coconut oil, along with a rich bacon flavor.

Sales of natural pet supplement sales nearly doubled between 2008 and 2011, and with an increasing focus on pet health, the market for pet supplements is projected to show significant and continuing expansion (http://cnw.fm/66NhV). Estimates show that U.S. retail sales of pet supplements and nutraceutical treats will grow 3 to 5 percent annually, bringing the market to almost $1.6 billion. Globally, the pet supplement market is also expected to experience tremendous growth.

Steinberg said, “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health. Our hempSMART product line will continue to expand to other popular areas of consumer interest to give our affiliates what they need to succeed.”


Wellness Environment Shifting toward CBD


The wellness industry is growing rapidly, generating an estimated
$3.72 trillion annually (http://cnw.fm/d3Zs5). In addition, the attitude in the wellness environment is shifting regarding premium quality cannabinoid products. MCOA is one of the prominent companies working to give consumers access to technological innovations and the highest quality hemp-derived products.

Specifically designed to support normal bodily functions such as energy, flexibility, and overall wellness,
hempSMART products are only the beginning for MCOA and its hempSMART division. MCOA is committed to find, test, and deliver the finest natural ingredients focused on wellness and personal care combined with the added benefits of hemp-based cannabinoids.

In addition to dedicating itself to the development of CBD-based nutritional products, MCOA is focused on educating and empowering consumers to learn about and become part of the hemp movement, thus allowing its customers to benefit from some of the world’s most innovative hemp products. The company is also dedicated to
supporting the resurgence of green sustainable hemp-based products and technologies that have a positive effect on the environment.

Others Positioning in the Market

MCOA
isn’t the only company deeply committed to making its presence felt in the burgeoning hemp and cannabis industries.

AbbVie
(NASDAQ: ABBV) is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. With a cannabis-based drug already available on the market, pharmaceutical company AbbVie, is ahead of the pack in this industry. Its FDA-approved Marinol is approved for chemotherapy-induced nausea and vomiting and anorexia, and the drug may also help AIDS patients who have lost their desire to eat.

CV Sciences, Inc.
 (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company’s PlusCBD Oil™ has achieved immense success since the launch of its brand of dietary supplements. The brand is currently being sold in approximately 1,300 health food stores and continues to grow its shelf presence in various retail outlets across the country. "It's evident that hemp-derived CBD products are doing better and growing faster than almost every other category in the supplement industry, and it's been a long time since we've seen a supplement trend truly demonstrate demand in such an immense fashion," said Stuart Tomc, vice president of human nutrition and spokesperson for CV Sciences. "There are no barriers to acceptance as the idea of hemp-derived CBD is finally ripe. Consumers are embracing hemp-derived CBD.”

The premier packaging company in the rapidly growing legal, regulated marijuana industry,
KushCo Holdings, Inc. (OTCQB: KSHB) is a dynamic sales and distribution platform that provides packaging, supplies, vaporizer products, hydrocarbons, accessories, and branding services to cannabis manufacturers, processors and retailers. Founded in 2010, Kush Bottles now has 12 facilities throughout the United States, a sales presence in every major cannabis market, and strives to be the go-to supplier and thought leader for businesses in the cannabis industry. KushCo recently announced that it had partnered with MainStem, a technology-based ancillary product distribution company for the regulated cannabis industry, to be the inaugural partner for MainStem’s Vendor Program (MVP).

An industry leading producer of medical cannabis, Aurora Cannabis, Inc (OTCQX: ACBFF) operates a 55,200-square-foot, state-of-the-art production facility in Mountain View County, Alberta, and a second 40,000-square-foot, high-technology production facility in Pointe-Claire, Quebec. In January 2018, Aurora's 800,000 square-foot-flagship cultivation facility located at the Edmonton International Airport was licensed. When at full capacity, this facility is expected to produce over 100,000 kg per annum of cannabis. Aurora is also completing a facility in Lachute. In addition, the company just announced its intention to acquire MedReleaf Corp. (TSX: LEAF). This proposed transaction will bring together two of Canada's premier cannabis companies with fully aligned strategic visions and production philosophies, as well as complementary assets, distribution networks, products, and capabilities. The combined company will meet what Aurora and MedReleaf management teams consider to be the critical success factors in the industry, creating a powerful platform for accelerated growth on a global scale.

For more information about
Marijuana Company of America, please visit Marijuana Company of America (OTC:MCOA).

 About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
|
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)


About IBN

Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com

Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado

www.CannabisNewsWire.com
303.498.7722 Office

Editor@CannabisNewsWire.net

 Media Contact:
FN Media Group, LLC

NNW@FinancialNewsMedia.com  
+1-(954)345-0611

Source:  CannabisNewsWire

 

 

CBD Solid Bedrock as US Heads Back to Industrial Hemp Roots


New York, NY – May 24, 2018 – NetworkNewsWire.com News Coverage:  With the announcement in April of the Industrial Hemp Farming Act of 2018, the industry could be looking at a federal redefinition of hemp. Industrial hemp is a great source for CBD (cannabidiol), a non-psychoactive cannabinoid with numerous medical applications ranging (http://cnw.fm/7tqIy). U.S. market projections for hemp range from $1.9 to $2.1 billion within the next two years and could hit $3 billion by 2021, according to one industry analyst (http://cnw.fm/MLA5w). This is great news for well-positioned sector players such as Marijuana Company of America (OTC:MCOA), which recently executed a sizeable hemp-cultivation JV agreement. Other similarly positioned companies, such as Vancouver’s Aurora Cannabis, Inc. (TSX:ACB) (OTC:ACBFF), UK-based GW Pharmaceuticals Plc (NASDAQ:GWPH), Medical Marijuana, Inc. (OTC:MJNA) and Rocky Mountain High Brands, Inc. (OTC:RMHB), are also in position to exploit the burgeoning CBD market.

If passed alongside companion House Bill 5485, the Hemp Farming Act would effectively remove hemp from regulation as a controlled Schedule 1 substance, restoring the plant’s historic status as an important U.S. agricultural commodity. With Senate Minority Leader Chuck Schumer and fellow Democrat Senator Michael Bennet from Colorado signing on to the Hemp Farming Act with Republican Senator Cory Gardner from Colorado, the bill now looks to have strong bipartisan support. A recent report from Brightfield Group issued prior to the announcement of the Hemp Farming Act estimated that the hemp-derived CBD products component of the hemp market alone could hit $1 billion by 2020 (http://cnw.fm/Z9l9K). Industrial hemp has a storied history in America, having been cultivated from Colonial times through World War II and being essential to war efforts throughout that period. Given that the plant is a robust source for strong natural fiber and oils used to make everything from canvas and rope to building materials and fuel, it seems likely that the nation will indeed see the plant returned to its historical status as a core agricultural commodity.

Cultivation and Legal CBD Enable Agile Positioning

In an industry run by pioneering industry veterans who have lived through the legislative ups and downs that have ebbed and flowed since the earliest days of the cannabis market, the looming passage of the Cannabis Act in Canada and the potential of legislation such as the Marijuana Justice Act in the United States are encouraging signs that the industry has rounded the corner into the home stretch on legalization. CEO of Marijuana Company of America (OTC:MCOA) Don Steinberg actually founded the first publicly traded U.S. marijuana company, Medical Marijuana Incorporated. MCOA already has a strong hand in the rapidly emerging market for industrial hemp-based CBD products, as well as its strategic cultivation-focused JV with B.C.-based Global Hemp Group that began in New Brunswick Canada last year and which has now expanded to 125 acres of commercial production.

The tip of the spear for MCOA in CBD is wholly owned subsidiary hempSMART™, whose affiliate marketing program and shrewdly engineered networking architecture, as well as upcoming major marketing campaigns that include a sixty second are designed to not only capture maximum market share but bolster customer retention as well. An offering such as hempSMART’s patent-pending “hempSMART Brain” product, which is designed to support healthy brain function, is an arguably compelling exploitation of CBD’s increasingly apparent antioxidant and neuroprotective functions (http://cnw.fm/Vh8bo).

Capacity Is Key Moving Forward

The recent JV agreement between MCOA and Global Hemp Group (which also has base operations in Montreal and Los Angeles) focused on cultivation of legal, high-yielding CBD from industrial hemp at a newly acquired 109-acre farm in Scio, Oregon. This move should significantly enhance the company’s market presence (http://cnw.fm/Owe9r). With the purchase of 20,000 high-yield CBD clones along with onsite clone production to meet an early June planting schedule target, assessment of key greenhouse technologies needed to maximize floor space and enable the JV’s perpetual harvest model, as well as the purchase of an additional 12,096 square feet of greenhouses for an intial total of nearly 20,000 square feet of production space, the JV is well on its way to having a superb high-yield CBD project in one of the country’s most cannabis-friendly states.

Additionally, the company recently announced completion of an initial10,000 square foot greenhouse just south of the Canadian border in Washington State, developed via JV with agricultural services company Bougainville Ventures (http://cnw.fm/m8GaT). This first leg of a planned 30,000-square-foot facility is a major step towards realizing a sizeable production facility in a key jurisdiction that will become the home of several licensed tenants that will be looking for just such an ideal turnkey solution to satisfy their growing needs.

Sector Outlook Grounded in CBD and Biopharma

A strong footing in the already legal CBD market with the infrastructure to also potentially supply the growing medical and recreational markets throughout North America has put Marijuana Company of America (OTC:MCOA) on the radar of many sector analysts. Savvy investors will want to compare the company’s rapidly expanding footprint with that of other sector players that also stand to benefit from pending legislative reform.

Aurora Cannabis, Inc. (TSX:ACB.TO) (OTCQX: ACBFF), a licensed Canadian producer of medical cannabis, recently estimated that it will surpass 90,000 kg of output by the end of this year and see revenues of around $70 million. With an 800,000-square-foot flagship facility at the Edmonton International Airport (estimated to be able to produce 100,000 kg of cannabis a year at full capacity), a 55,200-square-foot facility in Alberta, and another 40,000-square foot facility in Quebec, Aurora is uniquely positioned to become a major supplier that may even surpass rival Canopy Growth (WEED.TO) (OTC: TWMJF), which recently moved to list its shares on the NYSE. Moreover, Aurora’s plan to buy all common shares of MedReleaf (LEAF.TO) (OTC: MEDEFF), if approved, would create a true industry juggernaut, one estimated by financial services firm Canaccord Genuity to have the potential to eventually produce a whopping 570,000 kg of cannabis per year.

GW Pharmaceuticals Plc (NASDAQ: GWPH) is one of the most well-established cannabis biopharmaceutical companies in the space today, boasting a proprietary cannabinoid product platform that has given rise to such highly publicized indications as the anti-seizure CBD-based drug Epidiolex®. Along with its U.S. subsidiary Greenwich Biosciences, the company recently announced publication in The New England Journal of Medicine of Phase 3 study results of its oral CBD drug in a form of rare childhood-onset epilepsy known as Lennox-Gastaut syndrome. Many sector analysts argue that the NDA for GWPH’s oral CBD solution in Lennox-Gastaut and (similar) Dravet syndromes is likely to be approved by the FDA. Such an approval would mean the drug could become available by prescription in the the United States in the second half of 2018.

Medical Marijuana, Inc. (OTC: MJNA) portfolio companies Hempmeds®, Kannaway and Kannalife™ Sciences have been receiving more and more coverage of its internationalized distribution of products such as Real Scientific Hemp Oil™. The company’s CEO, Dr. Stuart Titus, was recently featured as part of a Buzzfeed article on CBD that reached a massive audience, even as the company’s portfolio company, HempMeds Brasil, was in the news for sponsoring the upcoming medical marijuana-focused “A Look into the Future” International Medicinal Seminar. That announcement came just days after the news that HempMeds has partnered with Northshore Pharmacy in Bermuda to sell the company’s flagship CBD oil products.

Rocky Mountain High Brands, Inc. (OTCQB: RMHB) recently announced that hemp products in its new and cutting-edge CBD-infused product line, known as HEMPd, are available for purchase on both Amazon and eBay. The company’s popular and naturally flavored energy drinks, Rocky Mountain High Hemp Infused Beverages, have been doing solid business in Canada since the initial one million can order shipped back in 2016. Rocky Mountain High is looking forward to potentially enjoying some serious momentum as Canada moves towards legalization, with one of the most widely recognized brands today in functional hemp food and drink. A roughly $3.6 million deal executed late last year with a major food and beverage distributor in Mexico, where marijuana is soon to be legalized, means RMHB looks to be well on its way to becoming one of the leading hemp-infused food and beverage purveyors on earth.

Sector Sentiment Appears Positive to Many Analysts

While there were major concerns for the cannabis sector last year and earlier this year, companies poised to exploit CBD and broader cannabis demand are eyeing the softening tone in the United States, as well as forthcoming Canadian legalization of all cannabis, as major boons to the industry. For a company such as MCOA, which has good access to the North American market and an established presence in CBD, the best may be yet to come.

For more information about Marijuana Company of America, please visit Marijuana Company of America (OTC:MCOA).

About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)
About IBN
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com
Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com
+1-(954)345-0611

SOURCE: CannabisNewsWire

 

MARIJUANA COMPANY OF AMERICA AND GLOBAL HEMP GROUP PROVIDE UPDATE ON NEW BRUNSWICK HEMP PROJECT


ESCONDIDO, CA -- May 22, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to provide an update on its New Brunswick Hemp Project with joint venture partner, Global Hemp Group Inc. (CSE: GHG/ OTC: GBHPF/ FRANKFURT: GHG) (the “Partners”).

The Partners have hired Joan Parker-Duivenvoorden as fulltime project agrologist and field manager for the project. Ms. Parker-Duivenvoorden graduated from Guelph University in 1981 with a BSc (Agr) majoring in plant protection. She has over 15 years-experience with the Nova Scotia Dept of Agriculture and with the New Brunswick Soil and Crop Improvement Association (“NBSCIA”). While working at the NBSCA, she has developed strong ties in the farming community that will prove to be advantageous as the project expands from the initial group of four farmers to more than fifty farmers as envisioned in coming years. In addition to being responsible for the project locally, she will provide advisory services to participating farmers, will conduct on-farm research projects to properly monitor the behaviour of various hemp varieties in different environments of the region. She will also develop training materials to assist farmers who will join the project in subsequent years. One of the long-term research projects headed by Ms. Parker-Duivenvoorden will be to develop a profitable crop rotation for organic hemp, opening the way for organic CBD.

Contracts have now been signed with the initial group of four farmers, who began seeding this season’s 125-acre industrial hemp crop last week. The farmers participating in the project in 2018 are located throughout the northeastern region of New Brunswick, Canada, making for a good cross section of results for research conducted on the behavior of the crop across that region. The distribution of farms will maximize the demonstration effect and will facilitate the recruitment of additional farmers in the following years. This carefully selected group of farmers will actively participate in addressing the introduction of this new crop across different regions.

A 4,000 sq. ft. facility has now been secured in Bathurst, New Brunswick for the project. The building will be used for biomass storage and to install drying equipment that will used to process the fresh material. Dried material will be stored at the facility while awaiting further processing by third party processors. Once proper licenses have been acquired for importing and manufacturing finished CBD products, the site may also serve as a distribution center for the hempSMARTTM and Benihemp line of products.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Source: Marijuana Company of America, Inc.

 

Marijuana Company of America’s Joint Venture Completes set up of 10,000 sq ft. Greenhouse


ESCONDIDO, CA -- May 17, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to announce that its Washington based Joint Venture with Bougainville Ventures, Inc. has completed the setup of 10,000 sq. ft. of greenhouse space. The greenhouse is pending the completion of inspection, which is the final step needed before commencing cultivation.

Marijuana Company of America - Cannabis Greenhouse in Washington State
Marijuana Company of America (MCOA), in a joint venture with Bougainville Ventures, Inc., has erected the first 10,000 square feet of a 30,000-square-foot greenhouse facility for cannabis cultivation in Washington. When fully built out, the facility will have the capacity to house approximately 4,000 marijuana plants.


The first 10,000 of a 30,000 square foot facility has been fully erected and is ready for inspection this week along with the newly installed security system. The construction crew is currently focused on installing the wiring and mounting panels, plugs and switches, the HVAC system and fans. The Company expects that the final inspection of the security and greenhouse construction will be sometime this week. Once the inspection is approved, the tenant grower will be allowed to occupy the space and begin growing.

Donald Steinberg, MCOA CEO said, "As landlords we are looking forward to providing a turnkey property to the first of hopefully many licensed tenants in Washington. Providing a turnkey facility for tenant growers is an ideal cultivation environment for tenants with minimal start-up capital and consistent rental income for MCOA.”

Once the 30,000 sq. ft. facility is fully built-out, it will have the ability to house approximately 4,000 plants.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name "hempSMART™", that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Bougainville Ventures, Inc.
Bougainville Venture Inc. is in the core business of converting irrigated farmland that was traditionally used to grow marginally profitable feed crops, to greenhouse-equipped farmland used to grow luxury crops with a primary focus on marijuana. Bougainville is an agricultural services company that focuses on providing growers with state-of-the-art computer controlled greenhouses and processing facilities. Bougainville offers fully built out turnkey solutions to licensed tenant-growers and luxury crop growers who will lease the facilities for production and processing. Bougainville does not "touch the plant" and only provides growing infrastructure as a landlord for licensed marijuana growers.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Source: Marijuana Company of America, Inc.

 

Global Hemp Group and Marijuana Company of America Provide an Update on Operations for Their Joint Venture CBD Hemp Farm in Scio, Oregon


ESCONDIDO, CA -- May 15, 2018 --GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) and joint venture partner MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) (the “Partners”) are pleased to provide an update on their CBD hemp farming project in Scio, Oregon (the “Project”).

Garden operations are well underway at the farm. The initial nursery and propagation rooms for clones has recently been expanded to an additional attached greenhouse as the team continues to produce clones for planting in the current season. In order to maximize planting density, an additional 20,000 high yielding CBD hemp clones are being purchased and will be delivered before the end of May to meet the targeted planting schedule of early June.

The team will be planting the clones on the first 35 acres at the farm. They will be planted “orchard style”, 4 to 5 feet on center, with rows 5 feet apart to provide space for each plant to receive sufficient sunlight, water and nutrients, and mature to maximum size to produce the highest CBD yield possible upon harvest.

Five additional greenhouses have now been purchased for the project. The first two 30ft. x 120ft greenhouses are currently being installed and will provide an additional 7,200 sq. ft. of greenhouse space for the project. The three remaining 42ft x 96ft greenhouses will begin installation before the end of May. When installed, these additional greenhouses will increase greenhouse space by a further 12,096 sq. ft., for a total of 19,296 active greenhouse space.

The Scio farm will employ both traditional outdoor orchard style cultivation and perpetual harvest in greenhouses. The Partners are currently evaluating additional greenhouse technologies for expansion of indoor cultivation space to augment its perpetual harvest model square footage. This dual strategy will optimize revenue generation throughout the year to minimize the impact of single crop harvesting in October when most other hemp CBD farms harvest and typically drive prices down. Market prices tend to climb throughout the year as less biomass is available for processing and distribution, as is occurring with current market prices. By August it is expected that full spectrum CBD oil will be in tight supply and prices will continue to climb until after the October 2018 harvest season is processed.

The team is in the process of ordering the required equipment to facilitate farm operations from planting through harvesting, drying and storage.

In addition, the Partners are currently evaluating a field analytics software application to be employed for data collection and analysis to optimize farming operations. The software will be used to evaluate the three cultivation methods being employed by the Partners in 2018; high yielding CBD cultivars grown orchard style outdoors in Scio, Oregon, perpetual harvest in greenhouses also at Scio, and traditional dense field cropping with lower yielding CBD cultivars in New Brunswick, Canada. Results will assist the team in determining optimal yield per acre for future expansion of acreage in both the United States and Canada.

“The Scio Oregon high yielding CBD hemp project is something that we have been working on putting together most of this year. It’s great to see that the project is now officially underway, and we look forward to sharing pictures and results of the operation as we go forward”, stated Charlie Larsen, President of Global Hemp Group.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

For more information, visit http://globalhempgroup.com

Forward Looking Statements. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

 

MARIJUANA COMPANY OF AMERICA AND GLOBAL HEMP GROUP FORM JOINT VENTURE TO CULTIVATE HIGH YIELDING CBD HEMP IN SCIO, OREGON


ESCONDIDO, CA -- May 9, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to announce that is has signed a Joint Venture Agreement (the “Agreement”) with GLOBAL HEMP GROUP INC. (“GHG”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) to cultivate legal high yielding CBD from industrial hemp at its recently acquired 109 acre farm (see news release of May 1, 2018) in Scio, Oregon.

Pursuant to the terms of the Agreement, MCOA and GHG (the “Partners”) will jointly invest a total of US$1.2 million in the development of the project in 2018. Funding for the project will be done on a 50/50 basis.

TTO Enterprises Inc. (“TTO”) will manage and be responsible for the entire Scio project, and will also provide consulting services to the Partners’ 125-acre joint venture hemp farm operations in New Brunswick, Canada. TTO’s expertise includes genetics development, selection and management, planting and harvest scheduling, clone management, field preparation, field set and field management strategies.

MCOA and GHG will continue to develop a robust North American joint venture relationship focused on hemp. The Partners initially joint ventured on hemp trials in New Brunswick Canada during 2017, which has now expanded to 125 acres of commercial production for 2018. This partnership has now expanded into the United States with the addition of the Scio, Oregon project. The Companies will continue to seek additional hemp cannabinoid production opportunities across the United States and Canada.

Don Steinberg CEO commented " we are really proud of the hard work our partners have put into this project, as we continue to execute this portion of our overall business plan. Activities such as these clearly put MCOA as a top line producer in the legalized hemp and processing arena".

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG)
, is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Source: Marijuana Company of America

 

Marijuana Company of America’s hempSMART™ Brand Engages Kim Castle and Verve Integrative to Manage Television Ad Campaign for Its CBD Product Line


ESCONDIDO, CA -- May 04, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary, H Smart, Inc. has engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television (DRTV) ad campaign to promote its hempSMART™ product line.

The Company anticipates that its recently announced EPCO direct sales marketing campaign, in conjunction with the upcoming DRTV marketing campaign and the Company’s ongoing network marketing campaign should result in an improvement in hempSMART™ product sales in Q3 and Q4 2018. The budget for the DRTV program is approximately $100,000.

hempSMART™ is working with Ms. Castle of Verve Integrative and their experienced marketing team to develop a market strategy and a television commercial for the hempSMART™ Pet Drops that will air on cable networks in select regions nationally this summer. The hempSMART™ commercial spot will have featured placement on the official eCommerce site of a well-known DRTV company and will be broadly promoted on integrated social media outlets, benefiting from well-established consumer engagement strategies.

Ms. Castle is leading a team that has more than 25 years of experience in many variations of media strategy, development and production, working for Disney, GM, ABC, Paramount, GreyGroup and McCann, to mention just a few. They specialize in multipoint story experiences designed to educate, entertain and endorse while mirroring the human mind’s process of solving a problem, thereby supporting consumers in making emotional and logical product conclusions. Ms. Castle’s experience both in front of and behind the camera provides an invaluable edge to the hempSMART™ marketing campaign.

In addition, Ms. Castle has personally been an advocate of CBD as an alternative to traditional products currently on the market. “We are very pleased to partner with hempSMART™ on their journey to bring such thoughtful and well-developed products to the people who need natural relief and enhanced health solutions. I wish hempSMART™ Pet Drops were available to support my cherished dog when we were going through a health challenge together,” said Castle.

Donald Steinberg, CEO of MCOA, stated, “Kim’s experience gives us an excellent opportunity to greatly expand the marketing strategy for the hempSMART™ brand and product line. We are honored that the hempSMART™ product line will be managed by her and the Verve Integrative team. We look forward to the new television commercial airing this summer.”

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Source: Marijuana Company of America


Global Hemp Group and Marijuana Company of America Announce Acquisition of 109 Acres of Prime Agricultural Property for Hemp CBD Production in the State of Oregon


ESCONDIDO, CA -- May 01, 2018 --  GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) is pleased to announce that the Company, in partnership with MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), has acquired a 109 acre agricultural property in Scio, Oregon (the “Property”) for the cultivation of high CBD yielding hemp for the upcoming 2018 growing season.

This particular property was chosen as it has a history of hemp cultivation over the last two growing seasons and contains a high level of organic matter in the soil, which makes it ideal for hemp cultivation. In addition, the property has appropriate irrigation infrastructure that includes sufficient authorized water rights to allow for irrigated cultivation, which is expected to greatly enhance yields of the proposed high CBD hemp cultivars that the partners are planning to grow on the property.

The property, located in the fertile Willamette Valley approximately 70 miles south of Portland, Oregon, was acquired for US$1.1 million. The terms of the acquisition include a cash down payment of US$130,000 and the issuance of 2,100,000 common shares in the share capital of GHG valued at US$275,000, to be delivered within 15 days of closing. The partners are each contributing one half of the cash consideration for the down payment purposes, or the amount of US$65,000. MCOA is also contributing a cash payment equal to one-half of the value of GHG’s stock consideration, or the amount of US$137,500, that will be paid from the expected profits to be produced from the project during the first year of operations.

The GHG common shares to be issued pursuant to the Acquisition Agreement are considered to be issued on a private placement basis, according to the CSE Policy 6. Such common shares are subject to a customary one (1) year hold period pursuant to the provisions of Rule 144 of the Securities Act of 1933. The balance, the amount of US$695,000, is a promissory note (“the Note”) issued to the current owner, which matures on May 1, 2021. Interest on the Note is set at 4.0% per annum, adjustable on the first day of October each year, based on the closing interest rate of the Ten-Year U.S. Treasury Note on September 30th plus 1.15%. The Note calls for monthly payments of US$7,036.54 beginning as of June 1, 2018, and a final payment of the remaining balance on May 1, 2021.

The partners have been exploring hemp cultivation and cannabinoid extraction opportunities in the U.S. Pacific Northwest for more than a year. The State of Oregon was chosen for this project due to climate considerations, the current regulatory environment in the State and availability of local experienced personnel.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

Forward Looking Statements Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Source: Global Hemp Group Inc.
 

Marijuana Company of America’s Joint Venture Completes Set-Up of 7,000 sq. ft. Greenhouse Facility in Washington State


ESCONDIDO, CA -- April 18, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"), an innovative hemp and cannabis corporation, is pleased to announce that its joint venture project, BV-MCOA Management, LLC, has completed the construction of three greenhouses totaling 7,000 square feet. This represents the completion of more than 23% of the total 30,000-square-foot cultivation facility.

The Company entered into the joint venture agreement with Bougainville Ventures, Inc. on March 16, 2017, and subsequently arranged for $800,000 funding for the purchase of the land and the construction of the greenhouses. Transfer of ownership of the property to the joint venture is pending completion of the final subdivision of the property by the Okanogan County Assessor.

The construction team constructed a total of 7,000 sq. ft. in greenhouse space in preparation for the 2018 planting season. Final inspection of the security system and greenhouse construction is expected to be completed in the coming weeks. Once the final inspection is approved, the licensed tenant can occupy the facility and begin cultivation.

Donald Steinberg, MCOA CEO said, "We are pleased to see the completion of the first phase of the greenhouse facilities. Once the security system is in place, we are confident the site will pass final inspection allowing our tenant-growers to occupy the facility and begin operations. MCOA continues to explore opportunities to replicate this business model and expand our real estate portfolio."

The joint venture will lease the turnkey property to a licensed tenant, thereby acting solely as a landlord. As a turnkey landlord, the joint venture aims to provide an ideal cultivation environment for its future tenant, and it is anticipated that greenhouse will be completed by the beginning of Q3 2018. The completed 30,000 square foot cultivation facility will have a capacity of approximately 4,000 plants.

About Bougainville Ventures, Inc. Bougainville Venture Inc. is in the core business of converting irrigated farmland that was traditionally used to grow marginally profitable feed crops, to greenhouse-equipped farmland used to grow luxury crops with a primary focus on marijuana. Bougainville is an agricultural services company that focuses on providing growers with state-of-the-art computer controlled greenhouses and processing facilities. Bougainville offers fully built out turnkey solutions to licensed tenant-growers and luxury crop growers who will lease the facilities for production and processing. Bougainville does not "touch the plant" and only provides growing infrastructure as a landlord for licensed marijuana growers.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About BV-MCOA Management, LLC
On March 16, 2017, the Company and Bougainville Ventures, Inc. entered into a joint venture agreement that included the purchase of land in Washington State, and plans to build out facilities on the land to support leased agricultural growth, including licensed cannabis operators. As amended on November 6, 2017, the Company’s financial commitment to the joint venture was fixed at contributing $800,000, and the issuance of 15 million shares of restricted common stock to Bougainville. The Company completed its payment on November 9, 2017. The funding arranged for by the Company provided consideration for the purchase of the land and contributed to the build out of the facility. The land is pending legal transfer to the joint venture after subdivision is completed by the Okanogan County Assessor. The Company and Bougainville are currently revising and restating their joint venture agreement to resolve certain discrepancies and inconsistencies. The Company and Bougainville expect to complete this restatement shortly and once completed, the Company will disclose it on Form 8-K filed with the Securities and Exchange Commission. For more information about MCOA and BV-MCOA Management, Inc., please refer to the Company’s disclosures with the Securities and Exchange Commission (www.sec.gov).

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Source: Marijuana Company of America

 

Marijuana Company of America Engages Eddy Pham & Company to Launch Comprehensive hempSMART™ CBD Retail Marketing Campaign


ESCONDIDO, CA -- March 27, 2018 -- MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA) ("MCOA" or the "Company"),

an innovative hemp and cannabis company, is pleased to announce that it has engaged Eddy Pham & Company (EPCO) to provide retail marketing and advertising services for its hempSMART™ branded products.

Eddy Pham & Company is a direct to consumer full-service marketing company that will provide MCOA’s hempSMART product line with a fully integrated, multi-channel transactional marketing campaign focused on digital advertising, infographics, content marketing, customer incentives and acquisition, a broad social media presence as well as search engine marketing and optimization that includes comprehensive research and analytics. EPCO will also be providing outsourced customer service and fulfillment services for hempSMART orders made through their campaign.

Since 1993, EPCO’s CEO, Mr. Eddy Pham has had a long and successful career managing transactional marketing campaigns. Mr. Pham has been involved in the product development, manufacturing, distribution, and campaign marketing of a number of the well-known product lines on the market. With the experience gathered from managing the manufacturing for over 160 products, EPCO is poised to help the hempSMART family of products be successful from building brand equity to overall increased sales. EPCO will utilize its partnerships within the transactional industries to help bring hempSMART to consumers who are looking for all natural, hemp-derived, full spectrum CBD and other future cannabinoid (CBC, CBG, CBN) based proprietary formulated products that are in development.

CEO Donald Steinberg, stated, “MCOA is honored to have EPCO on as a marketing partner for our hempSMART product line. The impressive marketing strategy that EPCO will be implementing with our products will help secure hempSMART as one of the leading hemp-based cannabinoid companies in North America.”

Eddy Pham states, “In over two decades of product development and transactional marketing, I can say that hempSMART produces quality products that truly work. I personally have not been this excited in a long time to work on a product line that can truly bring relief to its users.”

About Our hempSMART Products Containing CBD The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

About Eddy Pham & Company
Eddy Pham & Company is a direct to consumer full service company that focuses on transactional marketing, product development, distribution, and operational campaign management. EPCO has branded and launched over 160 recognized and successful brands over the last 25 years. The company offers a collection of end to end services spanning various media verticals focusing on revenue enhancement.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA
Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Source: Marijuana Company of America

 

-------------------------------------------------------------------
About Marijuana Company of America, Inc.:


Marijuana Company of America (OTC: MCOA) offers investors the opportunity to be on the forefront of innovation in the legal cannabis and industrial hemp industries. We strive to produce a diverse portfolio of synergistic companies that provide value to our shareholders. Our vertically integrated business model provides our company’s and partnerships the best position for rapid growth. Turn-key facilities will provide individuals with only the highest quality ingredients that ensures our costumer’s loyalty, where our distribution platform, hempSMART™, is strongly positioned to capture market share by developing recognizable brands through unique ways to promote to individuals.

Marijuana Company of America Inc. was established as a publicly traded company “MCOA” in 2015 by Don Steinberg and Charles Larsen, two veterans of the cannabis and industrial hemp industries. Their goal was to capture a piece of the $6.7 billion cannabis and $688 million hemp industries which have been enjoying exponential growth with no slowdown in sight.

The objective is to create an umbrella under which we would place a variety of portfolio companies that participate within this industry. Taking on a long term vision and recognizing the many potential opportunities that exist, we have established ourselves along various points in the cannabis, industrial hemp, and related services supply chain.

Our wholly owned subsidiary hempSMART™ delivers all of the benefits of industrial hemp derived cannabinoid (non THC) products to the world through its unique marketing and distribution platform. MCOA, also, provides turn-key services to the legal cannabis and hemp industry, as well as, strategically investing in synergistic companies to develop a diverse portfolio of subsidiaries and joint ventures that create value for our shareholders.

As MCOA embarks on its 2nd year, we find ourselves with many new partners, joint venture relationships, and a very powerful consortium of companies who share our global vision.

We are in the right business, at the right time, with the right experience to take this company to the next level.

MCOA is publicly traded on OTC Markets under symbol MCOA.

We are building a portfolio of investments and joint ventures that represent the highest integrity and professionalism in the legal cannabis and industrial hemp markets. MCOA will be a model for entrepreneurs and businesses that share our common goals and philosophies of not only creating value for investors, but also creating an environment for businesses to improve the quality of life of our customers through healthy, sustainable alternatives to many products currently on the market.

Become hempSMART
HempSMART™ is a company with a mission of educating and empowering consumers to learn about and become part of the Hemp Movement. This includes consuming and benefiting from some of the world’s most innovative hemp product technologies created by hempSMART.

Our mission is to make potential consumers “hempSMART.” Seeing the wellness environment rapidly shifting regarding premium quality cannabinoid products, the hempSMART founders have selected key professionals for various roles on the hempSMART team. This includes many of the best wellness professionals, health professionals, product formulation experts, educators, marketers and business minds to ensure that hempSMART can place you in a “first to market” position in every way.

The products are only the beginning.
Those that join the hempSMART Mission can start improving their personal wellness from day 1 with hempSMART products as well as become involved in this rapidly emerging industry with unlimited potential in the marketplace. Our product philosophy is to provide consumers with the newest, most innovative products, research and delivery systems related to hemp and CBD based products to improve their personal wellness.

HempSMART also provides a low barrier to entry business opportunity for entrepreneurs in a rapidly emerging, global marketplace.

HempSMART is is about to become a major industry brand with global operations providing wellness and opportunity for potentially millions of people.

Joint Venture
Pursuant to the joint venture, Marijuana Company of America, Inc. is committed to raising up to one (1) million dollars in funding provided to Bougainville Ventures to construct and manage a turnkey state of the art cultivation and processing facility in Oroville, Washington. The 30,000 sq.ft. greenhouse grow will house a Tier-3 production and processing I-502 tenant with decades of experience in high yields, consistency and quality.

MCOA will provide investors updates as the project progresses. MCOA management is in negotiations on deals with similar terms in other legal MMJ states.

The Focus
Bougainville Ventures Inc. (Bougainville) is an agricultural services company that focuses on providing growers with state-of-the-art computer controlled greenhouses and processing facilities. Our clients can focus on expanding their market share with minimal capital investment. We create solutions for our tenant-grower partners to become their primary growing infrastructure or to expand the bandwidth of their current farming infrastructure. Bougainville intends to offer fully built out turnkey solutions to licensed I-502 tenant-growers and luxury crop growers who will lease the facilities for production and processing.

A Re-Defined Network / The All-In-One Solution
MoneyTrac Technology, Inc. is a majority owned subsidiary of Global Payout, Inc. and is a pioneer in offering a full-service solution for alternative banking and electronic financial solutions.

MoneyTrac provides all aspects of financial technology including E-Wallet and mobile apps services for businesses and companies in various “high-risk” industries.

MoneyTrac’s technology platform allows for its clients to access their financial information from anywhere in the world, in addition to providing tracking and compliance to help them manage and control the flow of all revenue through their business.

With the legalization of cannabis sweeping the nation, financial compliance is a big factor toward obtaining licensing for various sectors of this industry.

“The electronic payment and compliance features available through the MTT technology platform are the solutions many sectors of our Cannabis industry have been looking for, and I look forward to providing the MTT Board with guidance and support to help move their objectives forward in the most effective way possible,” said Mr. Steinberg MCOA CEO.

MCOA intends to invest $250,000 in exchange for 15% of MTT, a subsidiary of Global Payout (OTC: GOHE).

Joint venture with GateC Research
Pursuant to the joint venture with GateC Research (“GRC”), MCOA is committed to raising million dollars to fund joint venture operations. This joint venture is for the purpose of cultivation, processing and distribution of legal cannabis within the state of California. GRC has successfully managed multiple legally compliant cultivation projects in multiple states, with their expertise we can expect state of the art facilities that produce high returns.

By replicating our production and processing model in California, the 6th largest economy in the world, MCOA has the opportunity to expand operations significantly.

Marijuana Company of America (MCOA) and Global Hemp Group (GHG) are launching agricultural hemp trials in northeast New Brunswick. It marks the return of industrial hemp to the region where it was tried 20 years ago but failed to take off due to lack of market opportunities. These trials are part of the first of three phases in implementing the Company’s Hemp Agro-Industrial Zone (HAIZ). The project focuses on the development of an industrial cluster around the hemp crop, which will ensure a market for farmers, year-round manufacturing job opportunities for the region, and a model for the Company to attract and develop additional HAIZ projects in other regions as well as provide a consistent potential revenue stream for both the MCOA and GHG shareholders.

Space Cowboys operates boutique and specialized lawful hemp farms in the state of Colorado for the primary purpose of Cannabinoid research, production and sales. Space Cowboys’ operations are in full compliance with Colorado state law and holds two licenses with the Colorado Department of Agriculture. Space Cowboy’s farms are up to date with all Department of Agriculture required filings, testing, and reporting. SC farms cultivate with minimal pesticides and uses only those pesticides approved by the Colorado Department of Agriculture.

SOURCE: http://marijuanacompanyofamerica.com/




Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty five hundred dollars for Marijuana Company of America, Inc.. coverage by the company.  FNMG HOLDS NO SHARES OF Marijuana Company of America, Inc.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.